The agency affirmed the use of biopsies for biomarker-driven trials but cautioned against optional biopsies that offer little value to the patient or trial.
GlobalData on MSN12h
Senseera secures $7.1m in funding to advance liquid biopsy platformThe platform analyses gene expression and cell states specific to individual cells, offering insights for disease diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback